全球无创产前检测 (NIPT) 市场

到 2030 年，全球无创产前检测 (NIPT) 市场规模将达到 92 亿美元

2024 年全球非侵入性产前检测 (NIPT) 市场规模估计为 49 亿美元，预计到 2030 年将达到 92 亿美元，2024-2030 年分析期内的复合年增长率为 10.9%。 NIPT 耗材和试剂是报告分析的细分市场之一，预计复合年增长率为 8.5%，到分析期结束时将达到 55 亿美元。在分析期内，NIPT 设备部分预计将以 15.2% 的复合年增长率成长。

美国市场规模估计为 13 亿美元，中国市场预计复合年增长率为 14.0%

预计 2024 年美国无创产前检测 (NIPT) 市值将达 13 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 21 亿美元，2024-2030 年分析期间的复合年增长率为 14.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 7.7% 和 8.7%。在欧洲，预计德国的复合年增长率约为 8.2%。

全球无创产前检测 (NIPT) 市场 - 主要趋势和驱动因素摘要

为什么非侵入性产前检测（NIPT）会出现在产妇照护领域？

非侵入性产前检测（NIPT）为孕妇提供了一种更安全、更准确的方法来检测胎儿的染色体异常，从而迅速改变了产前护理。 NIPT 分析母亲血液中存在的无细胞胎儿 DNA，以识别唐氏症、爱德华氏症候群和帕陶氏症候群等遗传疾病。与羊膜穿刺术和绒毛膜绒毛取样等有流产风险的传统侵入性手术不同，NIPT 可提供可靠的结果且风险最小。此检查通常在怀孕初期进行，适用于高风险妊娠，以便儘早做出决策并更好地进行产妇护理管理。随着人们对基因筛检认识的提高，NIPT 正在成为常规产前筛检的重要组成部分。

NIPT 市场的关键部分有哪些？

关键技术包括次世代定序仪（NGS）、微阵列和聚合酵素链锁反应（PCR），其中以NGS应用最为广泛，因为它可以同时高精度地检测多个遗传标记。在应用方面，NIPT主要用于检测唐氏症（21三体症）、爱德华氏症候群（18三体症）、帕陶氏症候群（13三体症）等三体症。其他应用包括检测性染色体异常和微缺失。 NIPT的主要终端使用者是医院、诊断实验室和产科诊所，基因检测正在成为产前护理的标准组成部分，尤其是对于35岁以上的女性和有遗传病史的女性。

NIPT 如何融入产前护理和诊断？

医院和产科诊所正在将 NIPT 作为高风险怀孕常规产前筛检的一部分，早期发现染色体异常对于医疗决策至关重要。诊断实验室使用 NIPT 提供全面的基因筛检服务，通常与医疗保健提供者合作以确保及时获得结果和后续护理。研究机构正在探索 NIPT 除了染色体异常之外的潜力，例如筛检单基因疾病和更广泛的遗传学见解。此外，远端医疗服务促进了远距咨询和 NIPT 的获取，使得服务不足地区的孕妇更容易获得 NIPT。医疗保健提供者和孕妇对 NIPT 的认识和接受度不断提高，支持了其在当代产前护理中发挥的作用。

哪些因素推动了非侵入性产前检测（NIPT）市场的成长？

非侵入性产前检测（NIPT）市场的成长受到多种因素的推动，包括对早期和准确的产前筛检的需求不断增长，尤其是在高风险妊娠中。次世代定序和其他基因分析技术的进步使得 NIPT 更加准确、高效、经济实惠且易于取得。人们对遗传疾病的认识不断提高以及早期检测的好处也促进了 NIPT 的广泛应用。多个国家对 NIPT 的监管核准，加上政府对产妇保健的支持，进一步推动了市场的成长。此外，远端医疗服务和直接面向消费者的测试模式的扩展使 NIPT 更加容易获得，加速了其在世界各地孕妇中的应用。

部分

产品（消耗品/试剂、设备）；方法（母体血浆中的无细胞 DNA 检测、超音波检测、生化筛检测试）；应用（三体性、微缺失症候群、其他应用）；最终用途（诊断实验室、医院）

受访公司范例（总合33家）

• Agilent Technologies, Inc.
• Berry Genetics Inc.
• BGI Genomics Co. Ltd.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Igenomix
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Natera, Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Yourgene Health

目录

第一章调查方法

第 2 章执行摘要

• 市场概况
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章 市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲国家
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Non-Invasive Prenatal Testing (NIPT) Market to Reach US$9.2 Billion by 2030

The global market for Non-Invasive Prenatal Testing (NIPT) estimated at US$4.9 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. NIPT Consumables & Reagents, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the NIPT Instruments segment is estimated at 15.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 14.0% CAGR

The Non-Invasive Prenatal Testing (NIPT) market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Non-Invasive Prenatal Testing (NIPT) Market - Key Trends and Drivers Summarized

Why Is Non-Invasive Prenatal Testing (NIPT) Gaining Ground in Prenatal Care?

Non-Invasive Prenatal Testing (NIPT) is rapidly transforming prenatal care by offering expectant parents a safer and more accurate method for detecting chromosomal abnormalities in the fetus. NIPT analyzes cell-free fetal DNA present in the mother’s blood to identify genetic conditions like Down syndrome, Edwards syndrome, and Patau syndrome. Unlike traditional invasive procedures like amniocentesis or chorionic villus sampling, which carry risks of miscarriage, NIPT provides reliable results with minimal risk. The test is typically performed during the first trimester and is suitable for high-risk pregnancies, enabling early decision-making and better management of prenatal care. As awareness of genetic screening increases, NIPT is becoming an integral part of routine prenatal screening.

What Are the Key Segments in the NIPT Market?

Key technologies include next-generation sequencing (NGS), microarray, and polymerase chain reaction (PCR), with NGS being the most widely used due to its high accuracy and ability to detect multiple genetic markers simultaneously. In terms of application, NIPT is primarily used for detecting trisomies, including Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). Other applications include detecting sex chromosome abnormalities and microdeletions. The major end-users of NIPT include hospitals, diagnostic laboratories, and maternity clinics, where genetic testing is becoming a standard component of prenatal care, particularly for women over 35 or those with a history of genetic disorders.

How Is NIPT Integrated Across Prenatal Care and Diagnostics?

Hospitals and maternity clinics are incorporating NIPT as part of routine prenatal screening for high-risk pregnancies, where early detection of chromosomal abnormalities is crucial for medical decision-making. Diagnostic laboratories use NIPT to offer comprehensive genetic screening services, often in collaboration with healthcare providers to ensure timely results and follow-up care. Research institutions are exploring the potential of NIPT beyond chromosomal abnormalities, including screening for single-gene disorders and broader genetic insights. Additionally, telehealth services are facilitating remote consultations and access to NIPT, making it more accessible to pregnant women in underserved regions. The growing awareness and acceptance of NIPT among healthcare providers and expectant parents underscore its role in modern prenatal care.

What Factors Are Driving the Growth in the Non-Invasive Prenatal Testing (NIPT) Market?

The growth in the Non-Invasive Prenatal Testing (NIPT) market is driven by several factors, including the increasing demand for early and accurate prenatal screening, particularly in high-risk pregnancies. Advances in next-generation sequencing and other genetic analysis technologies have improved the accuracy, efficiency, and affordability of NIPT, making it more accessible. The rising awareness of genetic disorders and the benefits of early detection have also contributed to the broader adoption of NIPT. Regulatory approvals for NIPT in several countries, combined with government support for maternal healthcare, have further fueled market growth. Additionally, the expansion of telehealth services and direct-to-consumer testing models has made NIPT more accessible, increasing its adoption among expectant mothers worldwide.

SCOPE OF STUDY:

The report analyzes the Non-Invasive Prenatal Testing (NIPT) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables & Reagents, Instruments); Method (Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection, Biochemical Screening Tests); Application (Trisomy, Microdeletion Syndrome, Other Applications); End-Use (Diagnostic Laboratories, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Agilent Technologies, Inc.
• Berry Genetics Inc.
• BGI Genomics Co. Ltd.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Igenomix
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Natera, Inc.
• PerkinElmer Inc.
• Thermo Fisher Scientific Inc.
• Yourgene Health

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Global Economic Update
  • Non-Invasive Prenatal Testing (NIPT) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Early and Accurate Fetal Screening Spurs Growth in Non-Invasive Prenatal Testing Market
  • Technological Advancements in Cell-Free DNA Sequencing and Genomic Analysis Strengthen Business Case for Adoption
  • Growing Focus on Early Detection of Genetic Abnormalities Expands Addressable Market
  • Expansion of NIPT in Hospital Laboratories, Diagnostic Centers, and Clinics Fuels Market Growth
  • Increasing Adoption of NIPT in Routine Prenatal Care and Risk Assessment Expands Market Opportunities
  • Technological Innovations in Multi-Gene Panels and Whole Genome Sequencing Propel Market Expansion
  • Rising Focus on Reducing Invasive Testing Procedures and Pregnancy Risks Drives Demand for NIPT
  • Growing Use of NIPT in High-Risk Pregnancies, Advanced Maternal Age, and IVF Monitoring Expands Market Potential
  • Technological Advancements in AI-Powered Genomic Interpretation and Report Automation Propel Market Growth
  • Increasing Focus on Integrating NIPT with Digital Health Platforms and Telemedicine Drives Adoption
  • Rising Demand for NIPT in Personalized Maternal Care and Fetal Health Management Strengthens Global Market
  • Expansion of NIPT in Screening for Rare Diseases, Microdeletions, and Aneuploidies Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Ultrasound Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Ultrasound Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Biochemical Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Biochemical Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Cell-free DNA in Maternal Plasma Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Cell-free DNA in Maternal Plasma Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Microdeletion Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Microdeletion Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Non-Invasive Prenatal Testing (NIPT) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• JAPAN
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• CHINA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• EUROPE
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• FRANCE
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• GERMANY
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• INDIA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030
• AFRICA
  • Non-Invasive Prenatal Testing (NIPT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Method - Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Method - Percentage Breakdown of Value Sales for Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection and Biochemical Screening Tests for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Application - Trisomy, Microdeletion Syndrome and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Application - Percentage Breakdown of Value Sales for Trisomy, Microdeletion Syndrome and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by End-Use - Hospitals and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Non-Invasive Prenatal Testing (NIPT) by Product - Consumables & Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Non-Invasive Prenatal Testing (NIPT) by Product - Percentage Breakdown of Value Sales for Consumables & Reagents and Instruments for the Years 2015, 2025 & 2030

IV. COMPETITION